CN103948821A - Chinese herbal medicine pharmaceutical composition for preventing intestinal cancer - Google Patents
Chinese herbal medicine pharmaceutical composition for preventing intestinal cancer Download PDFInfo
- Publication number
- CN103948821A CN103948821A CN201410168533.0A CN201410168533A CN103948821A CN 103948821 A CN103948821 A CN 103948821A CN 201410168533 A CN201410168533 A CN 201410168533A CN 103948821 A CN103948821 A CN 103948821A
- Authority
- CN
- China
- Prior art keywords
- gram
- grams
- herba
- radix
- herbal medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese herbal medicine pharmaceutical composition for preventing intestinal cancer. The Chinese herbal medicine pharmaceutical composition is obtained by respectively crushing 8g-10g of ginseng, 8g-10g of cubilose, 6g-8g of gastrodia elata, 12g-15g of radix pseudostellariae, 12g-15g of tabasheer, 6g-8g of paris polyphylla, 6g-8g of semen cassia, 2g-3g of rhubarb root, 7g-10g of evergreen dogwood leaf and fruit, 8g-12g of marsdenia tenacissima, 8g-12g of oldenlandia diffusa, 8g-12g of sculellaria barbata, 8g-12g of rubia yunnanensis, 8g-12g of grifola, 8g-12g of rhizoma alismatis, 6g-8g of fructus aurantii, 6g-8g of plantain herb, 6g-8g of pangolin shell scale, 6g-8g of dry elephant skin, 2g-3g of cuttle bone, 6g-8g of agrimonia pilosa ledeb, 6g-8g of purple bergenia, 6g-8g of scutellaria baicalensis, 4g-6g of cordyceps sobolifera, 6g-8g of lysimachia christinae hance, 6g-8g of selfheal and 6g-8g of diversecolor cinquefoil into powder, sterilizing, and mixing, thereby obtaining a finished product. The Chinese herbal medicine pharmaceutical composition disclosed by the invention has the effects of effectively eliminating turbid toxic materials out of the body, diminishing inflammation and removing pus, and loosening bowel to relieve constipation, so that the body is anticancer, and therefore, cells, tissues and organs recuperate. Besides, the composition disclosed by the invention has satisfying effect for treating intestinal cancer and achieving postoperative rehabilitation.
Description
Technical field
The present invention relates to combination of oral medication, particularly the Chinese herbal medicine compositions of a kind of effective auxiliary treatment intestinal cancer and rehabilitation.
Background technology
Cancer morbidity increasing year by year, becomes normalization trend, the health that is endangering the mankind.Western medical treatment adopts after excision malignant tumor, in conjunction with radiotherapy more, and curative effect is consolidated in chemotherapy.Chinese medicine has been obtained accreditation widely in treatment cancer.Chinese herbal medicine, particularly Chinese herbal medicine handed down from one's ancestors among the people have been obtained useful effect in some cancer for the treatment of, the in the situation that patient having no result in hospitalize, or during in the face of the surgery cost of great number, Chinese herbal medicine is cheap with it, convenient, and toxic and side effects is little and be subject to the particularly welcome of vast rural patient of many people.
Summary of the invention
The object of this invention is to provide a kind of oral Chinese herbal medicine compositions, said composition adopts national folk use handed down from one's ancestors to fill a prescription for many years and effectively, and compositions has obtained remarkable result in auxiliary treatment intestinal cancer and postoperative rehabilitation, and cure rate is high.
A kind of anti-intestinal cancer Chinese herbal medicine compositions, is obtained than raw material preparation by following weight:
Radix Ginseng 8-10 gram, Nidus collocaliae 8-10 gram, Rhizoma Gastrodiae 6-8 gram, Radix Pseudostellariae 12-15 gram, Concretio Silicea Bambusae 12-15 gram, Rhizoma Paridis 6-8 gram, Semen Cassiae 6-8 gram, Radix Rumicis 2-3 gram, chicken sub-prime 7-10 gram, Caulis Marsdeniae Tenacissimae 8-12 gram, Herba Hedyotidis Diffusae 8-12 gram, Herba Scutellariae Barbatae 8-12 gram, Radix Rubiae Yunnanensis 8-12 gram, Polyporus 8-12 gram, Rhizoma Alismatis 8-12 gram, Fructus Aurantii 6-8 gram, Herba Plantaginis 6-8 gram, shell of Squama Manis scale 6-8 gram, dry elephant leather 6-8 gram, Os Sepiae 2-3 gram, Herba Agrimoniae 6-8 gram, Rhizoma Seu Herba Bergeniae 6-8 gram, Radix Scutellariae 6-8 gram, Periostracum cicadae 4-6 gram, Herba Lysimachiae 6-8 gram, Spica Prunellae 6-8 gram, Herba Potentillae Discoloris 6-8 gram, above each component is smashed respectively and is made powdery, 80 orders sieve, ultraviolet disinfection, mix homogeneously, be finished product.
Preferred feedstock weight ratio: 9 grams of Radix Ginsengs, 9 grams, Nidus collocaliae, 7 grams, Rhizoma Gastrodiae, 13.5 grams of Radix Pseudostellariaes, 13.5 grams of Concretio Silicea Bambusaes, 7 grams of Rhizoma Paridis, 7 grams of Semen Cassiaes, 2.5 grams of Radix Rumiciss, 8 grams of chicken sub-primes, 10 grams of Caulis Marsdeniae Tenacissimaes, 10 grams of Herba Hedyotidis Diffusaes, 10 grams of Herba Scutellariae Barbataes, 10 grams of Radix Rubiae Yunnanensis, 10 grams of Polyporus, 10 grams of Rhizoma Alismatis, 7 grams of Fructus Aurantiis, 7 grams of Herba Plantaginiss, 7 grams, shell of Squama Manis scale, 7 grams of dry elephant leathers, 2.5 grams of Os Sepiae, 7 grams of Herba Agrimoniaes, 7 grams of Rhizoma Seu Herba Bergeniaes, 7 grams of Radix Scutellariaes, 5 grams of Periostracum cicadaes, 7 grams of Herba Lysimachiaes, 7 grams of Spica Prunellaes, 7 grams of Herba Potentillae Discoloris.
Described each component herbal raw material is the commercially available prepared slices of Chinese crude drugs through cleaning, drying, cut into slices.Wherein, Rhizoma Seu Herba Bergeniae, Radix Scutellariae are got its root; Spica Prunellae, Herba Potentillae Discoloris, Herba Agrimoniae, Herba Lysimachiae, Herba Scutellariae Barbatae, Herba Plantaginis are got its herb; Caulis Marsdeniae Tenacissimae is got its rattan; Chicken sub-prime is got its fruit; Elephant leather is that resembling on corpse of natural death peels, and dries and obtains.
Each component effect of the present invention and potentiation show: Radix Ginseng, Nidus collocaliae, Rhizoma Gastrodiae, Radix Rubiae Yunnanensis, Radix Pseudostellariae, and effect is to improve body's immunity, the QI invigorating of refreshing oneself, the strong body of tonify deficiency; Concretio Silicea Bambusae, shell of Squama Manis scale, dry elephant leather, Os Sepiae, Herba Agrimoniae, Radix Scutellariae, Rhizoma Seu Herba Bergeniae, Spica Prunellae, Herba Potentillae Discoloris, effect is detumescence antiinflammatory, eliminating stagnation, hard, the convergence of bursting; Caulis Marsdeniae Tenacissimae, Herba Scutellariae Barbatae, Herba Hedyotidis Diffusae, Rhizoma Paridis energy effective antitumor; Radix Rumicis, chicken sub-prime, Semen Cassiae, Periostracum cicadae energy loosening bowel to relieve constipation, toxin expelling, heat-clearing and toxic substances removing; Polyporus, Rhizoma Alismatis, Fructus Aurantii, Herba Plantaginis, Herba Lysimachiae effect are relieving stranguria by diuresis toxin expellings, to change the gas of bladder water internal organs.In Mel, contain abundant vitamin, join drug administration of the present invention with hydromel, contribute to potentiation.
Generally speaking, comprehensive potentiation shows: effectively eliminating toxic substances to remove stasis, and row is dense in antiinflammatory, loosening bowel to relieve constipation, thus make body anticancer, cell, histoorgan are got well.Compositions of the present invention obtains promising result in treatment intestinal cancer and postoperative rehabilitation.
Method in clinical application: take every day once, each 24-35 gram, swallows with warm water or percentage by weight 10% hydromel, and dose looks body weight and the state of an illness is adjusted using dosage, body weight the lighter, state of an illness the lighter takes low dosage, otherwise uses high dose.Compositions of the present invention is nontoxic, and side effect is minimum.
Clinical effectiveness reference:
Detailed description of the invention
Now the present invention is done to further auspicious stating in conjunction with the embodiments, but be not limited to embodiment.
Embodiment 1,
Take raw material by following weight ratio:
Radix Ginseng 8-10 gram, Nidus collocaliae 8-10 gram, Rhizoma Gastrodiae 6-8 gram, Radix Pseudostellariae 12-15 gram, Concretio Silicea Bambusae 12-15 gram, Rhizoma Paridis 6-8 gram, Semen Cassiae 6-8 gram, Radix Rumicis 2-3 gram, chicken sub-prime 7-10 gram, Caulis Marsdeniae Tenacissimae 8-12 gram, Herba Hedyotidis Diffusae 8-12 gram, Herba Scutellariae Barbatae 8-12 gram, Radix Rubiae Yunnanensis 8-12 gram, Polyporus 8-12 gram, Rhizoma Alismatis 8-12 gram, Fructus Aurantii 6-8 gram, Herba Plantaginis 6-8 gram, shell of Squama Manis scale 6-8 gram, dry elephant leather 6-8 gram, Os Sepiae 2-3 gram, Herba Agrimoniae 6-8 gram, Rhizoma Seu Herba Bergeniae 6-8 gram, Radix Scutellariae 6-8 gram, Periostracum cicadae 4-6 gram, Herba Lysimachiae 6-8 gram, Spica Prunellae 6-8 gram, Herba Potentillae Discoloris 6-8 gram, above each component is smashed respectively and is made powdery, 80 orders sieve, ultraviolet disinfection, mix homogeneously, be finished product.
Embodiment 2,
Take raw material by following weight ratio:
9 grams of Radix Ginsengs, 9 grams, Nidus collocaliae, 7 grams, Rhizoma Gastrodiae, 13.5 grams of Radix Pseudostellariaes, 13.5 grams of Concretio Silicea Bambusaes, 7 grams of Rhizoma Paridis, 7 grams of Semen Cassiaes, 2.5 grams of Radix Rumiciss, 8 grams of chicken sub-primes, 10 grams of Caulis Marsdeniae Tenacissimaes, 10 grams of Herba Hedyotidis Diffusaes, 10 grams of Herba Scutellariae Barbataes, 10 grams of Radix Rubiae Yunnanensis, 10 grams of Polyporus, 10 grams of Rhizoma Alismatis, 7 grams of Fructus Aurantiis, 7 grams of Herba Plantaginiss, 7 grams, shell of Squama Manis scale, 7 grams of dry elephant leathers, 2.5 grams of Os Sepiae, 7 grams of Herba Agrimoniaes, 7 grams of Rhizoma Seu Herba Bergeniaes, 7 grams of Radix Scutellariaes, 5 grams of Periostracum cicadaes, 7 grams of Herba Lysimachiaes, 7 grams of Spica Prunellaes, 7 grams of Herba Potentillae Discoloris.
Embodiment 3,
The compositions of embodiment 1 or 2, every 24-30 gram compositions, joins 100 milliliters of the hydromels of percentage by weight 10% and takes.
Claims (3)
1. an anti-intestinal cancer Chinese herbal medicine compositions, it is characterized in that, obtained than raw material preparation by following weight: Radix Ginseng 8-10 gram, Nidus collocaliae 8-10 gram, Rhizoma Gastrodiae 6-8 gram, Radix Pseudostellariae 12-15 gram, Concretio Silicea Bambusae 12-15 gram, Rhizoma Paridis 6-8 gram, Semen Cassiae 6-8 gram, Radix Rumicis 2-3 gram, chicken sub-prime 7-10 gram, Caulis Marsdeniae Tenacissimae 8-12 gram, Herba Hedyotidis Diffusae 8-12 gram, Herba Scutellariae Barbatae 8-12 gram, Radix Rubiae Yunnanensis 8-12 gram, Polyporus 8-12 gram, Rhizoma Alismatis 8-12 gram, Fructus Aurantii 6-8 gram, Herba Plantaginis 6-8 gram, shell of Squama Manis scale 6-8 gram, dry elephant leather 6-8 gram, Os Sepiae 2-3 gram, Herba Agrimoniae 6-8 gram, Rhizoma Seu Herba Bergeniae 6-8 gram, Radix Scutellariae 6-8 gram, Periostracum cicadae 4-6 gram, Herba Lysimachiae 6-8 gram, Spica Prunellae 6-8 gram, Herba Potentillae Discoloris 6-8 gram, above each component is smashed respectively and is made powdery, 80 orders sieve, ultraviolet disinfection, mix homogeneously, be finished product.
2. anti-intestinal cancer Chinese herbal medicine compositions according to claim 1, is characterized in that, is obtained than raw material preparation by following weight:
9 grams of Radix Ginsengs, 9 grams, Nidus collocaliae, 7 grams, Rhizoma Gastrodiae, 13.5 grams of Radix Pseudostellariaes, 13.5 grams of Concretio Silicea Bambusaes, 7 grams of Rhizoma Paridis, 7 grams of Semen Cassiaes, 2.5 grams of Radix Rumiciss, 8 grams of chicken sub-primes, 10 grams of Caulis Marsdeniae Tenacissimaes, 10 grams of Herba Hedyotidis Diffusaes, 10 grams of Herba Scutellariae Barbataes, 10 grams of Radix Rubiae Yunnanensis, 10 grams of Polyporus, 10 grams of Rhizoma Alismatis, 7 grams of Fructus Aurantiis, 7 grams of Herba Plantaginiss, 7 grams, shell of Squama Manis scale, 7 grams of dry elephant leathers, 2.5 grams of Os Sepiae, 7 grams of Herba Agrimoniaes, 7 grams of Rhizoma Seu Herba Bergeniaes, 7 grams of Radix Scutellariaes, 5 grams of Periostracum cicadaes, 7 grams of Herba Lysimachiaes, 7 grams of Spica Prunellaes, 7 grams of Herba Potentillae Discoloris.
3. anti-intestinal cancer Chinese herbal medicine compositions according to claim 1 and 2, is characterized in that, adds 100 milliliters of the hydromels of percentage by weight 10% in every 24-35 gram compositions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410168533.0A CN103948821A (en) | 2014-04-17 | 2014-04-17 | Chinese herbal medicine pharmaceutical composition for preventing intestinal cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410168533.0A CN103948821A (en) | 2014-04-17 | 2014-04-17 | Chinese herbal medicine pharmaceutical composition for preventing intestinal cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103948821A true CN103948821A (en) | 2014-07-30 |
Family
ID=51326262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410168533.0A Pending CN103948821A (en) | 2014-04-17 | 2014-04-17 | Chinese herbal medicine pharmaceutical composition for preventing intestinal cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103948821A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593493A (en) * | 2004-06-24 | 2005-03-16 | 周忆青 | Therapy assisting agent and its preparation |
| CN102526638A (en) * | 2012-03-11 | 2012-07-04 | 覃德光 | Chinese medicinal preparation for treating liver cancer |
| CN102772745A (en) * | 2012-08-21 | 2012-11-14 | 卢速江 | Chinese medicinal preparation for treating cancer and preparation method thereof |
-
2014
- 2014-04-17 CN CN201410168533.0A patent/CN103948821A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593493A (en) * | 2004-06-24 | 2005-03-16 | 周忆青 | Therapy assisting agent and its preparation |
| CN102526638A (en) * | 2012-03-11 | 2012-07-04 | 覃德光 | Chinese medicinal preparation for treating liver cancer |
| CN102772745A (en) * | 2012-08-21 | 2012-11-14 | 卢速江 | Chinese medicinal preparation for treating cancer and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 张成铭等: "论复法大方在治疗恶性肿瘤中的临床运用", 《湖南中医药导报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041312B (en) | Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof | |
| CN101972454B (en) | Medicament for treating lymphoma | |
| KR101011285B1 (en) | Composition for relieving pain of lumber intervertebral disc and preparation method thereof | |
| CN101181529B (en) | Chinese medicine composition for curing tumor and preparation method thereof | |
| CN105918946A (en) | Red date and Chinese wolfberry fruit liver tonifying composition, granules and preparation method thereof | |
| CN102247479A (en) | Antitumor strong medicine and preparation method thereof | |
| CN106215118A (en) | Antineoplastic health preparation and preparation method thereof | |
| CN107184750B (en) | Medicine for treating chronic glomerulonephritis and nephrotic syndrome and preparation method thereof | |
| CN101816745B (en) | Chinese medicine composite applicable to treating ascitesduetocirrhosis and preparation method thereof | |
| CN102028890B (en) | Traditional Chinese medicine composition for treating uremia | |
| CN111437378B (en) | Traditional Chinese medicine composition and medicine for preventing and treating chronic heart failure and preparation method thereof | |
| CN103127272A (en) | Chinese medicinal preparation for treating breast disease and preparation method thereof | |
| CN103263582A (en) | Weight losing prescription | |
| CN103041233A (en) | Pharmaceutical composition for treating infantile diarrhea and preparation method thereof | |
| CN107952036B (en) | Traditional Chinese medicine preparation for reducing blood sugar and preparation method thereof | |
| CN105998936A (en) | Traditional Chinese medicine composition for treating chronic nephritis and renal insufficiency | |
| CN105456924A (en) | Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof | |
| CN103948821A (en) | Chinese herbal medicine pharmaceutical composition for preventing intestinal cancer | |
| CN105412755A (en) | Preparation method of medicament capsules with function of relieving radiotherapy reactions of tumor patients | |
| CN106334140A (en) | Traditional Chinese medicine composition and preparation method thereof | |
| CN104784547A (en) | Traditional Chinese medicine composition having synergistic effect on radiotherapy and preparation method | |
| CN103736009A (en) | Liomyoma nursing medicament and preparation method thereof | |
| CN104547695B (en) | It is a kind of for treating the pharmaceutical composition and its application of trigeminal neuralgia | |
| CN103933528A (en) | Traditional Chinese medicine composition for treating cardialgia caused by deficiency of heart qi | |
| CN105521150A (en) | Preparation method traditional Chinese medicine for reducing blood fat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140730 |
|
| RJ01 | Rejection of invention patent application after publication |